From the Labs

From the Labs: Biotechnology

  • Friday, September 1, 2006
  • By Emily Singer

New publications, experiments and breakthroughs in biotechnology--and what they mean.

   

Growing Brain Cells
Drugs that trigger the birth of neurons could provide the next generation of treatments for neurodegenerative diseases such as Parkinson's

SOURCE: "Dopamine D3 Receptor Agonist Delivery to a Model of Parkinson's Disease Restores the
Nigrostriatal Pathway and Improves Locomotor Behavior"
J. M. Van Kampenand C. B. Eckman
Journal of Neuroscience 26(27): 7272-7280

Results: Scientists at the Mayo Clinic in Jacksonville, FL, found that a drug similar to ones used to treat Parkinson's disease can spur growth of new neurons in the substantia nigra, the brain area damaged in the disease. In a study of rodents genetically engineered to model Parkinson's disease, twice as much neurogenesis, or birth of new neurons, was seen in animals treated with the drug as in control animals. Many of the newly generated cells appeared to develop into dopamine-producing neurons--the kind that are lost in Parkinson's. In addition, treated animals showed an 80 percent improvement in motor ability.

 

To read the entire article you must log in:

Most of our content — all daily news, blogs, and videos — is free. Magazine stories are paid. To read this story, you must have a subscription or you must use a reading credit. Registration to Technology Review is free and entitles registrants to three free reading credits.

Username or REGISTER
Password  
   
 
Advertisement

MAGAZINE

Can We Build Tomorrow's Breakthroughs?

Manufacturing in the United States is in trouble. That's bad news not just for the country's economy but for the future of innovation.

Videos

Meet 2011 TR35 Winner Jesse Robbins

More

Advertisement

Technology Review Lists

TR50

Our list of the 50 most innovative companies, including the following:

Lyric Semiconductor

Lattice Power

Calxeda

Applied Materials

More

Advertisement

Facebook

Advertisement